Cosmetotextiles with gallic acid: skin reservoir effect by Marti Gelabert, Meritxell et al.
Hindawi Publishing Corporation
Journal of Drug Delivery
Volume 2013, Article ID 456248, 7 pages
http://dx.doi.org/10.1155/2013/456248
Research Article
Cosmetotextiles with Gallic Acid: Skin Reservoir Effect
Meritxell Martí,1 Cristina Alonso,1 Vanessa Martínez,1 Manel Lis,2 Alfons de la Maza,1
José L. Parra,1 and Luisa Coderch1
1 Advanced Chemical Institute of Catalonia, (IQAC-CSIC), Jordi Girona 18-26, 08034 Barcelona, Spain
2 Terrassa School of Engineering (EET-UPC), Colom 1, 08222 Terrassa, Spain
Correspondence should be addressed to Meritxell Mart´ı; meritxell.marti@iqac.csic.es
Received 19 December 2012; Revised 8 March 2013; Accepted 11 March 2013
Academic Editor: Sophia Antimisiaris
Copyright © 2013 Meritxell Mart´ı et al.This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The antioxidant gallic acid (GA) has been incorporated into cotton (CO) and polyamide (PA) through two different vehicles,
that is, liposomes and mixed micelles, and their respective absorption/desorption processes have been studied. Moreover, in vitro
percutaneous absorption tests of different cosmetotextiles have been performed to demonstrate antioxidant penetration within the
layers of the skin. When GA was embedded into the cosmetotextiles, it always promoted a reservoir effect that was much more
marked than that observed for polyamide. Similar penetration was observed in the textiles treated with GA in mixed micelles or
liposomes in such compartments of the skin as the stratum corneum, epidermis, and even the dermis. GA was detected in receptor
fluid only when COwas treated withMM.This methodology may be useful in verifying how encapsulated substances incorporated
into textile materials penetrate human skin. Indeed, such materials can be considered strategic delivery systems that release a given
active compound into the skin at specific doses.
1. Introduction
Cosmetotextiles are garments designed to contact the skin
with the aim of transferring active substances useful for cos-
metic purposes, particularly to combat ageing effects [1–4]. In
fact, there are already several textile products on the market
that claim to have certain properties that are usually found
in pharmaceuticals or cosmetics [3], such as moisturising,
slimming, energising, refreshing, relaxing, vitalizing, or UV-
protecting properties, or are simply perfume. There is a real
need to develop test methods to demonstrate and verify the
effectiveness and durability of these claimed properties [5].
Encapsulation is one of the techniques used to apply
such substances to textiles [6]. Liposomes are biocompatible,
biodegradable, and nontoxic artificial vesicles formed by
lipids that can encapsulate many compounds (hydrophilic,
hydrophobic, and amphiphilic) for application to textiles.
Moreover, liposomes have been the subject of numerous
studies because of their importance as microencapsulation
devices for drug delivery and their applications in cosmetics
[7–10]. In fact, one way of enhancing drugs’ skin penetration
is the use of vesicular systems or liposomes [9, 10]. In this
study, a new strategy to enhance the delivery of an active agent
from a textile to the skin using mixed micelles (MMs) was
investigated. The micelles are composed of a lipid and a sur-
factant and are capable of transforming into liposomes when
the surfactant is eliminated by simple dilutionwithwater.The
potential ability of the MM to be structured as liposomes in
textile fabrics by dilution in water was investigated [11, 12].
Antioxidants are substances used as natural resources to
regulate processes considered external threats to the body,
preventing oxidative stress. One of the body’s defence systems
is the generation of endogenous antioxidants. The body also
incorporates exogenous antioxidants into the diet. It has been
demonstrated that when topically applied, these exogenous
antioxidants can diminish the effects of free radicals using
defence mechanisms similar to those of endogenous antioxi-
dants [13, 14].The encapsulation of antioxidants in liposomes
improves their therapeutic potential against oxidant-induced
tissue injuries, because liposomes facilitate intracellular deliv-
ery [15]. In this regard, textiles containing antioxidants might
have diffusion characteristics similar to those of transdermal
relize patches used in the field of pharmaceuticals. In this
study, the phenolic acid GA was used as an active principle
for its anti-inflammatory, antifungal, and antiviral properties
and the antioxidant protection it provides to our cells against
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free radicals [16]. The ability of GA to serve as a reliable
chemical tracer and its beneficial effects lend support to its
incorporation into a textile designed to be used in contact
with the skin.
In the present work, the antioxidant GA has been incor-
porated into CO and PA through two different vehicles,
Lip and MM, and their respective absorption/desorption
behaviours have been studied [17]. The aim of this work was
to determine GA penetration from different biofunctional
textiles within the layers of the skin using a specific in vitro
percutaneous absorption method [18].
2. Methodology
2.1. Materials. The standard fabrics used were plain cotton
fabric (CO) (Bleached Desized Cotton Print Cloth, Style 400
ISO 105-F02) and spun polyamide fabric (PA) (Style 361,
ISO 105-F03). Liposomes were prepared using commercial
lipids (phospholipids) Emulmetik 900 (Lucas Meyer GMbH,
France), and mixed micelles were prepared using the same
lipids and the surfactant Oramix CG 110 (Caprylyl/Capryl
Glucoside) (Seppic Italia Srl, Italy). The antioxidant active
agent gallic acid (GA) (Sigma-Aldrich) was employed. All
chemicals used were of analytical grade. Methanol (HPLC-
grade) and distilled water were used for high-performance
liquid chromatography analysis with UV detection (HPLC-
UV). Methanol (Carlo Erba, France) was used to extract GA
from the textiles.
2.2. Liposome/MixedMicelle Preparation. Emulmetik 900 is a
waxlike soybean lecithin emulsifier with an enriched content
of phosphatidylcholine for use in the cosmetic industry and
was employed for Lip and MM formation. Lips containing
4% Emulmetik 900 (PC) and 2% gallic acid (GA) were
prepared using the thin-film hydration method reported
elsewhere [19]. PC (4 g) solubilised in chloroform was dried.
The lipid film was dispersed in 100mL of a 2% GA aqueous
solution, and multilamellar vesicles (MLV) were obtained.
MMs (30% surfactant, 4% PC, and 2% GA) were prepared by
solubilising all compounds in distilled water; solubilisation
was performed by gently shaking until clear solutions were
obtained. All activities took place at room temperature.
Dynamic Light Scattering (DLS) (Zetasizer Nano ZS
ZEN3600; Malvern Instruments Ltd., Malvern, Worcester-
shire, UK) was used to determine the size distribution and
polydispersity index of the Lip and MM. A noninvasive
backscattering technique was used to minimise multiple
scattering effects without the need to dilute the samples.
The measurement was performed at room temperature with
polystyrene cells (Ref 67.754 Sarstedt). The detection of the
light scattered was performed at an angle of 173∘. Each sample
was measured in triplicate. The data were interpreted by
correlating the particle size distribution with the intensity of
light scattered. All data were collected and analysed using the
software programme Dispersion Technology Software (DTS)
provided by Malvern Instruments Ltd.
To quantify the GA entrapped in the vesicles, a Lip
formulation was precipitated and separated from the super-
natant by centrifugation at 14000 RPM for 15 minutes using
a Centrifuge 5415-Eppendorf (Germany). After separation,
the supernatant was retained.The initial liposome dispersion
and the supernatant were diluted in isopropanol/water 1/1
and read spectrophotometrically at 269 nm (GA maximum
absorption) using a Cary BIO300 spectrophotometer. The
efficacy entrapment percentage of GA in the Lip was deter-
mined by taking into account the amount of the active
principle present in the entire liposome dispersion (GA Lip ),
as well as in the supernatant (GA supernatant ) (see (1)), using a
GA calibration curve:
%𝐸 =
GA Lip − GA supernatant
GA Lip
× 100. (1)
2.3. Textile Application: Absorption/Desorption Process. Lips
and MMs containing GA were applied onto CO and PA
fabrics in triplicate by bath exhaustion in a liquor ratio of 1/5
at 60∘C for 60min with manual stirring every 10 minutes. To
quantify the amount of Lip or MM absorbed into the fabrics,
the samples were weighed before and after application under
24 h standard ambient conditions (23 ± 2∘C and 50 ± 5%
relative humidity, ISO 554-1976).
To study the desorption process, the treated fabrics were
washed in three different water baths at room temperature;
the samples were weighed before and after each washing
with deionised water (1/5 bath ratio, 1/10 bath ratio, and 1/25
bath ratio, resp.) for 5min with magnetic stirring under 24 h
standard ambient conditions (23 ± 2∘C and 50 ± 5% relative
humidity, ISO 554-1976). Particle sizes were measured in
the baths after the exhaustion treatment and in the baths
after the first and third washings as described for the initial
formulations.
2.4. In Vitro Percutaneous Absorption Experiments (Franz
Diffusion Cells). For these studies, pig skin was used from
the unboiled backs of largewhite/Landrace pigs weighing 30–
40 kg. The pig skin was provided by the Cl´ınic Hospital of
Barcelona, Spain. After excision, the skin was dermatomed to
a thickness of approximately 500 ± 50𝜇mwith a Dermatome
GA630 (Aesculap, Germany). Skin discs with a 2.5 cm inner
diameter were prepared and fitted into static Franz-type
diffusion cells.
Skin absorption studies were initiated by applying 10𝜇L
of Lip or MM (approximately 70 𝜇g/cm2 GA) or by applying
the fabrics treated with the same Lip or MM (containing
approximately 150–250𝜇g/cm2 GA) onto the skin surface.
Between the textile and the skin, 20𝜇L of distilled water
was added to ensure close contact. A control skin disc
(without product application on the skin surface) was used
to rule out possible interferences in the analysis of GA
by HPLC-UV. According to the OECD methodology [20],
the skin penetration studies were performed for 24 h of
close contact between the textile and the skin. To increase
the contact pressure between the textile fabric and skin,
permeation experiments were also carried out by placing
a steel cylinder on the textile-skin substrate at a constant
pressure in accordance with standard conditions (125 g/cm2)
(ISO 105-E04, 1996) [21] (see Figure 1).
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Figure 1: Diagram of in vitro percutaneous absorption experiments.
After the exposure time, the receptor fluid was collected
and brought to a volume of 5mL in a volumetric flask. In
the case of the formulations, the skin surface was washed
with a specific solution (500𝜇L SLES (sodium lauryl ether
sulphate) (0.5%) and twice with 500 𝜇L distilled water) and
dried with cotton swabs. In the case of the textiles, the fabrics
were removed from the skin surface and collected together
with the top of the cell. In both cases, after eliminating the
excess GA from the skin surface, the stratum corneum of the
skin was removed using adhesive tape (D-Squame, Cuderm
Corporation, Dallas, TX, USA) applied under controlled
pressure (80 g/cm2 for 5 sec). The epidermis was separated
from the dermis after heating the skin to 80∘C for five
seconds.
GA was extracted from the different samples (surface ex-
cess, CO/PA or skin layers) using a methanol : water (50 : 50)
solution agitated in an ultrasonic bath for 30min at room
temperature.The receptor fluids were directly analysed. After
filtration on a Millex filter (0.22𝜇m,Millipore, Bedford, MA,
USA), the solutions containing GA were assessed by HPLC-
UV.
2.5. Gallic Acid Analytical Detection. The GA extracted from
the different samples was determined by HPLC equipped
with a UV-Vis detector as previously described [19]. The
column used was a LiChroCART 125-4/LiChrosorb RP-18
(5 𝜇m) (Darmstadt, Germany). The mobile phase was 80%
water/20% methanol flowed at a rate of 1mL/min. The GA
retention time was approximately 3.3min. The area under
curve was used to calculate the concentration of GA using
external standards that showed linearity over a concentration
range from 0.25 to 100 𝜇g/mL. Four textiles treated with the
formulation without GA were studied as blank samples. This
experimental methodology prevented any compound from
possibly interfering with the analysis of the target substance.
The analytical methodology was fully validated.
2.6. Data Treatment. Analysis of variance (ANOVA) was
used to determine significant differences between percuta-
neous absorption values obtained from different samples
Table 1: Mean size and polydispersity index (PDI) of initial
liposome (Lip) and mixed micelle (MM) formulations and their
dilutions in water.
Formulation Mean size (nm) PDI
Lip 717.40 ± 56.25 0.74 ± 0.03
10% Lip in water 407.47 ± 24.07 0.79 ± 0.03
5% Lip in water 367.80 ± 8.51 0.84 ± 0.10
2.5% Lip in water 395.07 ± 28.84 0.60 ± 0.14
MM 8.05 ± 0.08 0.13 ± 0.02
10% MM in water 8.23 ± 0.17 0.10 ± 0.01
5% MM in water 10.53 ± 0.06 0.14 ± 0.05
2.5% MM in water 55.35 ± 0.08 0.09 ± 0.01
(significant level accepted ∗𝑃 < 0.01) using the Statgraphics
program.
3. Results
Two textiles, CO and PA, were chosen to compare the roles
of two vehicles, two phospholipid structures (Lip and MM)
composed of the same phospholipids but with a surfactant
in the case of MM. Both vehicles were applied by bath
exhaustion, as it was explained in Section 2 to study the
absorption and desorption of GA.
The Lip formulation was prepared by thin-film hydration
method, as described in Section 2, with 4% phospholipids
(PC) and 2% GA in water. Polydisperse vesicle suspensions
(0.7 PdI) with especially large multilamellar vesicles (MLV
700 nm) were formed [22]. Vesicles of this type may contain,
on average, up to 10 bilayers [23].Themultilamellar structure
allows for high encapsulation efficiency for both hydrophilic
and hydrophobic substances, which can be localised not only
in the central core of the vesicle but also in the aqueous
interlamellar spaces or in the multiple lamellar spaces [24].
To quantify the GA entrapped in the vesicles, the Lip formu-
lationwas precipitated and separated from the supernatant by
centrifugation. The amount of GA in the initial Lip solution
and in the supernatant and the difference between themwere
evaluated as described in Section 2, yielding a fairly high
entrapment efficacy of 31.9 ± 9.6%.
In MM, the two constituent PC and the surfactant agent
are structured together in small micelles, giving rise to a
transparent solution. However, the dilution of MM promotes
the separation of the surfactant and thePCwith the formation
of liposomes.This results in a large increase in size, giving rise
to a turbid solution [7]. The absorption of micelles by textiles
could be maintained after washing because of the expected
increase in the size of the vehicles inside the textile fibres,
which could enhance the fixation of the micelles in textiles
with less desorption, as occurs in the skin [25, 26].
The variation in the vehicle sizes with dilution for the two
formulations is presented in Table 1. The Lip size decreases
from approximately 700 to 400 nmwith dilution, whereas the
MMs have an initial size of 8 nm and increase to 55 nm for a
dilution to 2.5% MM in water, as expected, due to liposome
formation with dilution. The PDI remained unaltered by the
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Table 2: Percentage of formulation remaining in PA and CO fabrics after treatment, after first water washing, and after total water washings.
Fabric Type of treatment Treatment (% owf) After 10mL wash (% owf) After total wash (% owf)
CO Lip 10.99 ± 0.39 7.32 ± 2.43 5.58 ± 0.39
CO MM 35.43 ± 2.73 12.72 ± 0.44 2.42 ± 0.06
PA Lip 16.34 ± 1.23 12.73 ± 1.94 7.31 ± 0.64
PA MM 40.14 ± 4.23 18.29 ± 1.98 3.91 ± 0.11
% owf:% over weight of fibre.
Table 3: Size (𝑍-average) and polydispersity index (PdI) of different baths of CO and PA subjected to bath exhaustion with Lip or MM.
Treatment Analysed bath Size (𝑍-average)diameter (nm) PdI
CO/Lip
Initial bath 525.6 ± 26.1 0.68 ± 0.03
Bath after exhaustion treatment 375.3 ± 64.6 0.51 ± 0.12
Bath after 1st water washing (10mL) 474.3 ± 32.2 0.68 ± 0.20
Bath after 3rd water washing (50mL) 623.5 ± 18.8 0.52 ± 0.03
CO/MM
Initial bath 6.9 ± 0.8 0.98 ± 0.04
Bath after exhaustion treatment 102.2 ± 30.9 0.98 ± 0.03
Bath after 1st water washing (10mL) 206.7 ± 76.5 0.34 ± 0.12
Bath after 3rd water washing (50mL) 211.0 ± 38.2 0.31 ± 0.02
PA/Lip
Initial bath 525.6 ± 26.0 0.68 ± 0.03
Bath after exhaustion treatment 460.6 ± 76.4 0.45 ± 0.01
Bath after 1st water washing (10mL) 510.0 ± 53.2 0.88 ± 0.21
Bath after 3rd water washing (50mL) 660.3 ± 31.9 0.49 ± 0.04
PA/MM
Initial bath 6.6 ± 0.8 0.97 ± 0.04
Bath after exhaustion treatment 157.2 ± 81.7 0.62 ± 0.17
Bath after 1st water washing (10mL) 257.6 ± 97.9 0.05 ± 0.12
Bath after 3rd water washing (50mL) 166.9 ± 89.5 0.34 ± 0.07
dilution effect in both lipid structures. The Lip PDI (>0.600)
was much higher than MM PDI (≅0.1), indicating a higher
dispersion for the big structures. Besides, it has to be pointed
out that the Lips were not extruded.
The active agents vehiculised in Lip (4% PC, and 2% GA
= 6% dry product) and MM (30% surfactant, 4% PC and 2%
GA = 36% dry product) were applied to the textile substrates,
CO and PA, by bath exhaustion as described in Section 2.The
initial and final percentages of dry product calculated by the
weight difference between the dry initial fabric and dry fabric
after bath exhaustion are shown in Table 2.
When the MMs were applied to the fabrics by an exhaus-
tion process, higher absorption than that in the Lip-treated
fabrics was observed. Nevertheless, extremely high desorp-
tion was observed due to the Lip treatment of both textiles. It
is important to note that PA absorbed much more MMs and
Lips than CO. The interaction of lecithin with CO has been
reported to occur mainly at the surface through a coating
layer, whereas the interaction with PA occurs in the interior
of the fibres [27].
The higher absorption of MM in CO and especially in PA
could be due to the presence of 30% Oramix. The increase
in particle size with dilution in the washing baths, which
reached up to 50–100 nm, did not prevent desorption. A large
amount of desorption occurs in MM-treated fabrics. The
separation of Lip composed of phospholipids and micelles
featuring Oramix could increase their affinity for water in
the two textiles, favouring desorption. The desorption of Lip
from the PA- and CO-treated fibres was approximately 50%,
whereas the desorption of MM from the PA- and CO-treated
fibres was 90%. The particle size of the lipid structures of Lip
andMMwas evaluated in the initial, after treatment, and after
washing baths (Table 3) to determine the possible influence
on product desorption.
A comparison of the results in Table 3with those obtained
for Lip andMMelution inTable 1 shows that in all the baths of
CO and PA, the Lip exhibited a similar size of approximately
500 nm. In the initial baths, the MM presented very small
sizes of approximately 7 nm. However, a size increase of up to
100–200 nm was already observed in the initial bath after the
treatment as well as in the washing baths. The concentration
of MM in the bath after textile treatment or after washing
treatments is much lower than the one assayed in Table 1; the
surfactant could have been removed in a high extent, and
lipids could have been organised as vesicles higher in size.
The extremely high absorption of MM could be due to the
easy penetration of the small structures into fabrics. However,
the increase in the size of these structures (see Table 3) did
not prevent their exit from the fibres, and desorption was
notable. This finding could be due to the higher permeability
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Table 4: In vitro percutaneous absorption of GA (gallic acid) in Lip and MM formulations and the PA and CO cosmetotextiles.
(a)
GA in formulations GA in Lip GA in MM
Compartments % 𝜇g/cm2 % 𝜇g/cm2
Total applied — 76.34 — 79.03
Wash/fabric 83.97 ± 0.40 55.08 ± 1.40 87.61 ± 1.87 59.38 ± 2.33
SC 6.78 ± 0.69 4.46 ± 0.55 4.41 ± 0.28 2.98 ± 0.14
E 1.37 ± 0.14 0.90 ± 0.07 1.14 ± 0.25 0.77 ± 0.15
D 1.20 ± 0.09 0.78 ± 0.04 1.07 ± 0.10 0.73 ± 0.05
R. F 6.68 ± 0.65 4.38 ± 0.36 5.77 ± 1.25 3.90 ± 0.77
Perc. Abs (E + D + RF) 9.25 ± 0.86 6.06 ± 0.48 7.98 ± 1.60 5.40 ± 0.9
Recovery 65.59 ± 1.65 67.76 ± 1.23
(b)
GA in CO GA in Lip on CO GA in MM on CO
Compartments % 𝜇g/cm2 % 𝜇g/cm2
Total applied — 147.95 — 242.61
Wash/fabric 91.84 ± 9.72 131.28 ± 14.38 87.34 ± 6.30 210.85 ± 15.68
SC 5.60 ± 1.42 8.60 ± 2.26 5.24 ± 1.02 12.64 ± 2.48
E 1.81 ± 0.87 2.78 ± 1.93 1.84 ± 0.35 4.45 ± 0.86
D 0.75 ± 0.41 1.15 ± 0.66 0.87 ± 0.54 2.12 ± 1.30
R. F 0.00 ± 0.00 0.00 ± 0.00 4.72 ± 0.44 16.10 ± 1.03
Perc. Abs (E + D + RF) 2.56 ± 0.92 3.93 ± 1.99 7.43 ± 0.51 22.67 ± 1.22
Recovery — 143.81 ± 4.25 — 241.47 ± 11.69
(c)
GA in PA GA in Lip on PA GA in MM on PA
Compartments % 𝜇g/cm2 % 𝜇g/cm2
Total applied — 395.90 — 479.59
Wash/fabric 96.64 ± 5.56 403.30 ± 22.02 97.20 ± 6.21 464.15 ± 29.78
SC 2.51 ± 0.81 10.49 ± 3.21 2.52 ± 0.33 12.05 ± 1.57
E 0.66 ± 0.44 2.78 ± 1.76 0.22 ± 0.02 1.05 ± 0.08
D 0.33 ± 0.04 1.39 ± 0.16 0.06 ± 0.10 0.28 ± 0.49
R. F 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
Perc. Abs (E + D + RF) 0.99 ± 0.55 4.17 ± 1.85 0.28 ± 0.03 1.33 ± 0.09
Recovery — 417.75 ± 31.87 — 477.53 ± 27.71
SC: stratum corneum, E: epidermis, D: dermis, and R.F: receptor fluid.
of textiles compared with human skin, which may explain
why this effect was not observed [25, 26].
To study the penetration of active principles through
the skin, an in vitro methodology based on percutaneous
absorption is performed to demonstrate the delivery of an
encapsulated principle from a textile to the different layers of
the skin (stratum corneum, epidermis, or dermis).
The percutaneous absorption of the two formulations,
Lip (2% GA, 4% PC) and MM (2% GA, 4% PC, and 30%
Oramix CG 110), was evaluated, as were the CO and PA
textiles impregnated with the same Lip or MM. The two
formulations and the CO and PA textiles previously treated
with the formulations were placed in contact with the skin
discs as described in Section 2.
The aim of this assay was to demonstrate tracer delivery
into the different layers of the skin. GAs encapsulated inMMs
and Lips, which were either embedded or not embedded
in cosmetotextiles, were applied to the skin to study the
percutaneous absorption profiles of the agents. The GA ex-
tracted from a washing sample, the fabric, the stratum corne-
um, the rest of the epidermis, the dermis, and the receptor
fluid was analysed. The results are listed in Table 4 and
graphically represented in Figure 2.
Comparison of percutaneous absorption in percentage
indicates that it is higher when GA was applied as a for-
mulation (Lip or MM) than when it is applied through
cosmetotextile. Besides, CO delivers to the skin GA in a
greater extent than PA.
As shown in Figure 2, the penetration of GA formulated
in Lip was much higher than that of GA formulated in MM.
All skin compartments showed a higher amount of GA when
vehiculised with Lip than when vehiculised with MM. This
result could be due to the bilayer structure of the Lip, which
is similar to the lipid bilayer structures present in the SC
and in the cellular membranes of the skin [28]. Evidence
that Lips do not penetrate deeper than the stratum corneum
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Figure 2: In vitro percutaneous absorption of gallic acid (GA) in
Lip and MM formulations and the PA and CO cosmetotextiles (SC:
stratum corneum, R. Fluid: receptor fluid) (significant level accepted
∗
𝑃 < 0.01).
layer has been published [29]. However, Lips enhance the
penetration of both hydrophilic and lipophilic drugs [30, 31].
However, both formulations promote the incorporation of a
significant amount of GA in all skin layers, as indicated by
the outstanding amount detected in the receptor fluid, which
accounts for the amount that would be present at a systemic
level.
Significant differences at a high level of ∗𝑃 < 0.01
can be visualized in Figure 2. Therefore, besides all previous
comments, it is important to remark the significant difference
between the amount of GA in the SC when applied Lip
related to its corresponding PA textile and between the two
formulations and their corresponding textiles in the deep
layers of the skin (dermis and receptor fluid).
When GA was embedded into the cosmetotextiles, a
marked reservoir effect was always induced. A lower degree
of GA skin penetration was obtained in most skin layers
compared with the results obtained for the formulation
application alone. A similar penetration profile was obtained
for the textiles treated with GA in MM or Lip in the skin
compartments, SC, epidermis, and even in the dermis. In
the dry textiles, the different lipid structures of Lip and MM,
which may induce different enhancement behaviours, were
lost.Therefore, textiles embedded with different vehicles may
be expected to play a similar reservoir role. It is important to
note that GA was absent in the receptor fluid of both the Lip-
treated textiles andMM-treated PA. GA was only detected in
the MM-treated CO fabric and in a smaller percentage than
that detected with the free formulations.
A comparison between the two textiles shows that much
higher global percutaneous absorption was observed in the
CO than in the PA fabric. GA was present in greater amounts
in all skin layers when CO cosmetotextiles were topically
applied and even reached the receptor fluid when applied
through MM. As in the washing desorption process, it
seems that PA has greater substantivity for GA than CO
vehiculised either in MM or Lip, because lecithin has been
reported to incorporate mainly on the surface of CO fibres,
whereas interaction with PA occurs to a greater extent in
the interior [27]. Therefore, it seems reasonable to predict
a higher reservoir effect for PA textiles, promoting a lower
percutaneous absorption of GA.
4. Conclusions
The precise amount of active agents present in cosmeto-
textiles was determined before being used in a textile drug
delivery system.Much greater absorption of the formulations
was found for the MM treatments relative to that observed
for the Lip treatments. However, the MM-treated fabrics
showed much higher desorption, leading to a lower amount
of absorbed material in the textile after washing. A large
increase in particle size from 7 to 200 nm was observed
for MM, which indicates Lip formation due to surfactant
dialysis. However, this increment in size does not help the
formulation remain in the textile; on the contrary, it favours
the desorption of the formulation.
The percutaneous absorption of two formulations, Lip
and MM, was evaluated, as was that of CO and PA textiles
impregnated with the same Lip or MM. The results indicate
that the penetration of GA formulated as Lip is much higher
than that when formulated as MM. The bilayer structure of
the vesicles, which is similar to the lipid bilayer structures
present in the stratum corneum and in the rest of the skin,
may account for their affinity.
WhenGAwas embedded in the cosmetotextiles, it always
promoted a reservoir effect, especially in the case of the
PA fabrics. A similar penetration profile was obtained for
the textiles treated with GA in MM or Lip in the different
skin compartments. GA was absent in the receptor fluid of
both Lip-treated textiles and in the MM-treated PA; it was
only detected in the MM-treated CO fabric and in a smaller
amount than that in the free formulations.This methodology
may be useful to verify the penetration through human skin
of encapsulated substances applied to textile materials, which
can be considered as strategic delivery systems for the release
of a given active principle at specific doses in the skin.
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